Načítá se...
Use of Placebos in Phase 1 Preventive HIV Vaccine Clinical Trials
Phase 1 preventive HIV vaccine trials are often designed as randomized, double-blind studies with the inclusion of placebo recipients. Careful consideration is needed to determine when the inclusion of placebo recipients is highly advantageous and when it is optional for achieving the study objectiv...
Uloženo v:
| Vydáno v: | Vaccine |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554766/ https://ncbi.nlm.nih.gov/pubmed/25454855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.10.017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|